Table 2.
Effect of leptin and camel milk on serum level of inflammatory cytokines of rats treated with valproic acid-induced autism.
| Treatments | TNF-Α (pg/mL) | IL-1β (pg/mL) | IL-6 (pg/mL) |
|---|---|---|---|
| Control | 18.025 ± 1.24A | 14.4 ± 4.6a | 4.9 ± 0.48a |
| VPA | 101.6 ± 6.3b | 116.05 ± 7.8b | 79.2 ± 5.3b |
| LEPT | 26.675 ± 0.99c,a | 28.62 ± 1.09a,c | 9.25 ± 0.41a,d |
| CAM | 35.225 ± 1.9c | 37.72 ± 2.1c | 16.12 ± 1.35a |
| VPA + LEPT (I) | 73.675 ± 3.5d | 82.25 ± 4.2d | 44.2 ± 2.6c |
| VPA + LEPT (II) | 49.125 ± 2.3e | 54 ± 2.4e | 17.8 ± 0.97d |
| VPA + CM | 50.575 ± 3.10e | 52.9 ± 2.9e | 31.975 ± 2.6e |
TNF: tumour necrosis factor; VPA: valproic acid; LEPT: leptin; CAM: camel milk.
Within each column, means superscript with different letters are significantly different (P < 0.05).